- Home
- HBCP vs LXRX Comparison
HBCP vs LXRX Comparison
Compare HBCP & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBCP | LXRX |
|---|---|---|
| Founded | 1908 | 1995 |
| Country | United States | United States |
| Employees | 481 | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.8M | 465.2M |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HBCP | LXRX |
|---|---|---|
| Price | $63.14 | $1.82 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $63.50 | $3.23 |
| AVG Volume (30 Days) | 23.0K | ★ 2.1M |
| Earning Date | 01-26-2026 | 03-05-2026 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 24.56 | N/A |
| EPS | ★ 5.62 | N/A |
| Revenue | ★ $145,087,000.00 | $70,864,000.00 |
| Revenue This Year | $2.60 | $56.61 |
| Revenue Next Year | $3.27 | N/A |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | 11.42 | ★ 1255.21 |
| 52 Week Low | $39.59 | $0.28 |
| 52 Week High | $63.67 | $1.66 |
Technical Indicators
Market Signals| Indicator | HBCP | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 65.98 | 79.59 |
| Support Level | $59.54 | $1.25 |
| Resistance Level | $62.02 | $1.41 |
| Average True Range (ATR) | 1.45 | 0.10 |
| MACD | 0.31 | 0.07 |
| Stochastic Oscillator | 82.79 | 99.24 |
Price Performance
Historical ComparisonAbout HBCP Home Bancorp Inc.
Home Bancorp Inc is engaged in attracting deposits from the public and using those funds to invest in loans and securities. The principal sources of funds are customer deposits, repayments of loans, repayments of investments and funds borrowed from outside sources such as the Federal Home Loan Bank of Dallas. These funds are used for the origination of loans, including one-to-four-family first mortgage loans, home equity loans, and lines, commercial real estate loans, construction and land loans, multi-family residential loans, commercial and industrial loans, and consumer loans.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.